What is MusclePharm?
Headquartered in Las Vegas, Nevada, MusclePharm operates within the competitive nutritional supplement industry. The company's core business involves the development, manufacturing, marketing, and distribution of a diverse range of branded nutritional products. MusclePharm aims to cater to a broad consumer base seeking performance and wellness solutions through its specialized formulations. The company's strategic positioning in the health and fitness sector is further solidified by its recent capital infusion.
How much funding has MusclePharm raised?
MusclePharm has raised a total of $29.1M across 4 funding rounds:
Stock Offering
$10.8M
Debt
$8M
Debt
$10M
Debt
$350K
Stock Issuance/Offering (2013): $10.8M with participation from The Frost Group
Debt (2014): $8M led by ANB Bank
Debt (2016): $10M supported by Prestige Capital Corporation
Debt (2020): $350K featuring PPP
Key Investors in MusclePharm
The Frost Group
The Frost Group is a London-based agency specializing in insolvency and business advice, offering mediation, business rescue, and liquidation services. They assist clients facing financial challenges.
PPP
Public-Private Partnership
Prestige Capital Corporation
Prestige Capital Corporation, operating with the domain prestigecapital.com, provided debt financing to MusclePharm. Their specific investment strategy or sector focus is not detailed.
What's next for MusclePharm?
The recent major strategic investment signals a pivotal phase for MusclePharm, likely enabling the company to accelerate its market penetration and enhance its product portfolio. This capital infusion is anticipated to support enhanced research and development efforts, potentially leading to innovative product launches and expanded distribution channels. MusclePharm's strategic financial backing positions it for continued growth and a strengthened competitive stance in the global nutritional supplement market.
See full MusclePharm company page
